Gen XY Updates from GlobeNewswire

2024-04-27T06:00:00Z
Dividend confirmationRegulated information - 26 april 2024


2024-04-27T00:38:46Z
VANCOUVER, British Columbia, April 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response...


2024-04-26T23:03:05Z
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES


2024-04-26T21:20:00Z
HORSHAM, Penn., April 26, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products...


2024-04-26T21:09:50Z
LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations,...


2024-04-26T20:51:11Z
WATERTOWN, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the “Company” or “Lyra”), a clinical-stage biotech developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic...


2024-04-26T20:45:00Z
TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20,...


2024-04-26T20:05:17Z
BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the...


2024-04-26T18:25:30Z
BEIJING, China, April 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sino Biological, Inc.("Sino Biological" or the "Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in biological...


2024-04-26T17:53:16Z
Comprehensive Treatment of Addiction and Mental Health Requires a Focus on Self-Love


2024-04-26T17:17:02Z


2024-04-26T16:03:00Z
Ólafur Þór Jóhannesson has decided to resign as Chief of Finance at PLAY airlines. Ólafur will remain as CFO at the company until his successor arrives.


2024-04-26T15:45:00Z
Paris, April 26 2024    Availability of the 2023 Universal Registration Document


2024-04-26T15:30:00Z
PRESS RELEASE - PRIVILEGED INFORMATION


2024-04-26T13:23:59Z
WARREN, N.J., April 26, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN) is a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T...


2024-04-26T13:20:00Z
CLEVELAND, OHIO, April 26, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or “Company”), an impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in...


2024-04-26T13:15:00Z
Bethesda, MD, April 26, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH”) (Nasdaq: HWH) announced today that it has entered into a joint venture through its subsidiary Health Wealth Happiness...


2024-04-26T13:12:00Z
COLUMBUS, Ohio, April 26, 2024 (GLOBE NEWSWIRE) -- Addressing the medication requirements of incarcerated individuals in U.S. correctional facilities has grown more challenging, particularly due to understaffing among nurses and...


2024-04-26T13:05:24Z
MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies,...


2024-04-26T13:02:57Z
Doctor Ashok Bharucha Proposes That Ibogaine Can Help Improve Immune System Functionality


2024-04-26T13:00:00Z
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS26 APRIL 2024 at 16.00 EEST


2024-04-26T12:30:00Z
SOUTH SAN FRANCISCO, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for...


2024-04-26T12:30:00Z
April 26, 2024


2024-04-26T12:30:00Z
WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive,...


2024-04-26T12:30:00Z
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors.


2024-04-26T12:30:00Z
— If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade —


2024-04-26T12:20:53Z
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES


2024-04-26T12:00:40Z
Not for distribution to United States news wire services or for dissemination in the United States


2024-04-26T12:00:00Z
Press release, Helsinki, 26 April 2024 at 3 PM (EEST)


2024-04-26T12:00:00Z
White Paper Details Recent Trends and Provides Current Industry Data and Analysis on the Growing Nutraceutical Industry


2024-04-26T12:00:00Z
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives...


2024-04-26T12:00:00Z
Company to host virtual investor event on Friday, May 3, 2024, at 4:30pm EDT following presentation of results from the Phase 3 BOND-003 trial at the 2024 AUA Annual Meeting


2024-04-26T11:55:16Z
This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line treatment of EGFR exon 20 insertion-mutated NSCLC


2024-04-26T11:15:00Z
WALTHAM, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the European Medicines Agency (EMA) has reset the review of the marketing authorization application...


2024-04-26T11:05:00Z
The Company will host a conference call and webcast on Wednesday, May 8, 2024 at 8:00 a.m. ET


2024-04-26T11:00:00Z
PITTSBURGH, April 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its first quarter 2024 financial results...


2024-04-26T11:00:00Z
AUSTIN, TX, April 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Interactive Strength Inc. (Nasdaq: TRNR) (“TRNR” or “the Company”), maker of innovative specialty fitness equipment under the CLMBR and...


2024-04-26T10:30:40Z
MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies,...


2024-04-26T10:16:43Z
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights...


2024-04-26T10:00:00Z
SAN JUAN CAPISTRANO, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and...


2024-04-26T09:33:27Z
COPENHAGEN, Denmark, April 26, 2024 (GLOBE NEWSWIRE) -- NetBet Denmark has agreed a partnership with iGaming company Habanero. This collaboration forms part of NetBet’s mission to enhance the gaming experience...


2024-04-26T08:15:00Z
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE26 APRIL 2024 at 11.15 EEST


2024-04-26T07:00:00Z
Planegg/Martinsried, April 26, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid...


2024-04-26T06:08:24Z
Oslo, Norway, April 26, 2024.The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according...


2024-04-26T06:00:00Z
Press release, Helsinki, 26 April 2024 at 9 AM (EEST)


2024-04-26T05:59:45Z
GUANGZHOU, China, April 26, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next...


2024-04-26T05:35:26Z
Havila Kystruten AS operates the four most environmentally friendly ships on the classic coastal route between Bergen and Kirkenes. The contract with the Ministry of Transport is for the period...


2024-04-26T05:00:00Z
Ad hoc announcement pursuant to Art. 53 LR


2024-04-26T04:27:06Z
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of its common...


2024-04-25T23:15:29Z
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting...